ILA — Island Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- AU$96.17m
- AU$83.30m
- AU$0.28m
Annual cashflow statement for Island Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1.88 | -2.7 | -3.16 | -2.77 | -4.83 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.88 | -2.7 | -3.16 | -2.77 | -4.83 |
| Capital Expenditures | — | — | — | — | -0.842 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | — |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | -0.842 |
| Financing Cash Flow Items | 0 | -0.18 | -0.33 | -0.247 | -0.584 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | -0.18 | 2.79 | 8.36 | 11.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.67 | -2.79 | -0.338 | 5.59 | 5.62 |